Clinical trial Recruiting at 1 site Interventional Ages 12 and up

Cryoneurolysis for disabling or painful shoulder and elbow hypertonia in cerebral palsy

Official title: Efficacy and Tolerability of Cryoneurolysis Treatment in Disabling and/or Painful Hypertonia of the Shoulder and Elbow in Patients With Cerebral Palsy Who Have Reached a Therapeutic Impasse a Pilot Study

Run by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française · NCT07321366 · Data updated 2026-11-12

This project will try ultrasound-guided perineural cryoneurolysis to reduce disabling or painful shoulder and elbow muscle tightness in people with cerebral palsy aged 12 and older.

More Cerebral Palsy (CP) trials

Quick facts

Study typeInterventional
Ages12 Years and up
SexAll
Enrollment40 (estimated)
SponsorCentre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Academic / other
Locations1 site (Lyon, Rhône)
StatusRecruiting
StartedDecember 22, 2025
Main results expectedDecember 15, 2028
Study endsDecember 15, 2028
Registry record updatedJanuary 8, 2026
Trial IDNCT07321366 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People with cerebral palsy aged 12 years or older who have disabling or painful hypertonia of the shoulder and/or elbow and who have contraindications to, inadequate response to, or unacceptable duration/coverage from standard therapies are ideal candidates.

Probably not a fit

Patients with fixed bony contractures or predominant generalized nonfocal spasticity, active infection or significant bleeding disorders, or those under 12 years old are unlikely to benefit from this focal cryoneurolysis approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center pilot offers ultrasound-guided percutaneous perineural cryoneurolysis targeted to nerves supplying spastic or dyskinetic muscles around the shoulder and elbow in people with cerebral palsy. Participants are patients treated at the CMCR des Massues who have disabling or painful hypertonia and who have reached a therapeutic impasse with oral drugs, botulinum toxin, or surgery. The protocol sets personalized short- and medium-term functional goals and collects clinical and patient-reported outcomes to characterize tolerability and preliminary efficacy. The focus is feasibility, safety, and estimating effect sizes to inform larger studies.

Why it matters

Potential benefit: If successful, this approach could provide a localized, minimally invasive option to reduce pain and muscle hypertonia and improve function when other treatments have failed or are not suitable.

How similar studies have gone: Small case series and observational reports indicate cryoneurolysis can reduce spasticity and pain, but randomized data and pediatric-specific evidence for shoulder/elbow application in cerebral palsy are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with cerebral palsy treated at the CMCR des Massues, regardless of their functional status as defined by their gross motor function level on the GMFCS (Gross Motor Function Classification System) and their manual ability level on the MACS (Manual Ability Classification System).
* Presenting with disabling and/or painful muscle hyperactivity in the shoulder and/or elbow,
* Aged over 12 years,
* At a therapeutic impasse: contraindicated or refusing surgery, contraindication or insufficient efficacy of oral treatments (analgesics, baclofen, Artane), too short duration of efficacy of toxin injections (\<3 months) and/or dose-weight limitation not allowing treatment of all necessary sites.
* Patient (and legal representatives in the case of a minor patient or guardian/curator in the case of an adult patient under legal protection measures) who has been informed and has signed the informed consent form for participation in the research,
* Patient affiliated with a social security scheme.

Exclusion Criteria:

* \- Patients who have received a botulinum toxin injection (any location) within 3 months prior to inclusion.
* Change in analgesic and/or antispastic treatment within 5 weeks prior to inclusion - Refusal to allow the patient's medical data to be used for research purposes
* Contraindication to peripheral motor block and/or cryoneurolysis (haemostasis disorder, skin infection, Raynaud's syndrome, cryoglobulinaemia, cold urticaria).
* Pregnant/breastfeeding patients.
* Cognitive and/or behavioural disorders that prevent participation in the study or giving consent to participate

Where it's running

  • CMCR des Massues
    Lyon, Rhône, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.